Catch the latest Race results and dirt track racing news! Plus a chance to get your friends and family on the special Christmas Show December 14th. That show will also feature armed forces member\'s video greetings!
Big efforts bring great results. Ron Arad and Javier Mariscal invited the winner of the 4th Edition of the international competition, Jump the Gap, Michael Warykiewicz, to join them in the mad Gala Ceremony created by Roca for the Award Ceremony, which brought together VIP's from the media and the design and architecture world. That was what they were cooking.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/roca/52776/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Reproductive Medicine Associates of New Jersey (http://www.rmanj.com) today presented interim findings from its BEST (Blastocyst Euploid Selective Transfer) trial, the first well-controlled clinical trial comparing in vitro fertilization (IVF) pregnancy rates in a group of women receiving a single embryo transfer (SET) with comprehensive chromosome screening (CCS) with a group receiving traditional morphology-based double embryo transfer (DET). The findings were presented at the American Society for Reproductive Medicine 68th Annual Meeting in San Diego, October 20-24, 2012.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58883-rmanj-best-trial-results-ivf-pregnancy-rates-women-asrm-annual-meeting
Nearly 12 million men in the U.S. suffer from symptoms related to benign prostatic hyperplasia (BPH), an enlargement of the prostate that can cause issues such as frequent and weak urinary streams and sleep deprivation from getting up repeatedly during the night to urinate. Since traditional BPH therapies such as daily medications and more invasive or surgical procedures often result in unwanted side effects and complications, more than 54 percent of men who would benefit from treating their BPH choose not to do anything1. With today’s national introduction of the FDA-cleared Rezūm® System, NxThera provides urologists and their patients suffering from symptomatic BPH with a new, safe and effective minimally-invasive, office-based treatment option which improves quality of life and preserves sexual function2 – one of the main reasons many men choose to forego medications or more invasive procedures.
“Men suffering from BPH are constantly evaluating the trade-offs between maintaining their current declined quality of life or treating their BPH symptoms and possibly incurring long term side effects,” said Dr. Kia Michel, M.D., a urologist at Comprehensive Urology in Los Angeles who recently performed the procedure as part of a nationally televised segment on prostate health. “Of all the minimally-invasive BPH treatments I’ve performed, Rezūm is the most effective and most versatile treatment available to patients – and the results have been excellent.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7933151-nxthera-rezum-therapy/
More than four in 10 workers (42 percent) in a new survey from global staffing firm Robert Half said they’re likely to look for a new job within the next year. For respondents ages 18 to 34, the number likely to seek new employment in the next 12 months jumps to 68 percent.
Part of the retention challenge for executives is understanding why a good employee might want to leave. Inadequate salary and benefits is the top reason workers said they would quit. However, CFOs reported the number-one reason they think good employees would resign is limited growth potential.
To view the multimedia release go to:
https://www.multivu.com/players/English/7764055-robert-half-retention-survey-results/
The St. Petersburg International Economic Forum (SPIEF) was held from June 20 to 22, 2013 – this year’s theme was “Finding Resolve to Build the New Global Economy”.
2013 was a record SPIEF year for the number of attendees – 7190 people attended, from 87 countries, out of which total there were 1245 media representatives. The Russian and international business community was well represented – SPIEF 2013 was attended by 176 major foreign corporations and 436 large-scale Russian businesses. Out of the companies who attended, 67 leaders of the foreign businesses, and 24 leaders of the Russian corporations have Forbes or Fortune listings. Moreover, 327 representatives of official foreign delegations attended SPIEF 2013.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61934-st-petersburg-international-economic-forum-results
The II Moscow International Forum for Innovative Development “Open Innovations”, which was held in Moscow from October 31 to November 1, 2013, confirmed its role of a global discussion platform in the field of technological innovations.
For two consecutive years now, “Open Innovations” has become the largest event in Russia and one of the biggest events in the world, demonstrating the major trends and key developments in innovative sectors of the economy. Open Innovations Expo 2013, which exposition has become a unique platform for the development and demonstration of advanced technologies, exchange of experience in successful implementing of innovative projects, as well as effective interaction between government, science and business was held within the framework of the Forum.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63505-results-open-innovations-forum-moscow-2013
Now entering its seventh year, diane magazine, published by Rodale Custom Content & Marketing on behalf of Curves fitness clubs for women, has now touched the lives of more than six million women.
To view Multimedia News Release, go to http://www.multivu.com/players/English/45110-rodale-marketing/
With years of business and military experience, this book plots your flight path to achieving the next level of growth in life and business. Learning to think like a fighter pilot will change how you approach everyday challenges and help shatter the barriers between you and the big blue open sky. Find out more at http://chuckgumbert.com Business/Non-Fiction
Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market and manufacturer of the industry's three premier brands: Thermage®, Fraxel®, and Isolaz®, is pleased to announce that it has partnered with PGA TOUR golfer Scott McCarron to raise awareness about skin protection and the Fraxel re:store® laser treatment. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin, including the removal of actinic keratoses (AK’s ) — a precancerous skin condition caused by sun exposure. Fraxel re:store treatment provides superior results for AKs on the face or other areas of the body displaying the signs of photodamage.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/solta/45388/
